1. Choi D, Crockard A, Bunger C, et al. Review of metastatic spine tumour classification and indications for surgery: the consensus statement of the Global Spine Tumour Study Group. Eur Spine J. 2010; 19:215–222.
2. Harel R, Angelov L. Spine metastases: current treatments and future directions. Eur J Cancer. 2010; 46:2696–2707.
3. Sciubba DM, Gokaslan ZL. Diagnosis and management of metastatic spine disease. Surg Oncol. 2006; 15:141–151.
4. Ecker RD, Endo T, Wetjen NM, Krauss WE. Diagnosis and treatment of vertebral column metastases. Mayo Clin Proc. 2005; 80:1177–1186.
5. Mut M, Schiff D, Shaffrey ME. Metastasis to nervous system: spinal epidural and intramedullary metastases. J Neurooncol. 2005; 75:43–56.
6. Cole JS, Patchell RA. Metastatic epidural spinal cord compression. Lancet Neurol. 2008; 7:459–466.
7. Dunning EC, Butler JS, Morris S. Complications in the management of metastatic spinal disease. World J Orthop. 2012; 3:114–121.
8. Schick U, Marquardt G, Lorenz R. Intradural and extradural spinal metastases. Neurosurg Rev. 2001; 24:1–5. discussion 6-7
9. Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, Akamaru T. Surgical strategy for spinal metastases. Spine (Phila Pa 1976). 2001; 26:298–306.
10. Galasko CS, Norris HE, Crank S. Spinal instability secondary to metastatic cancer. J Bone Joint Surg Am. 2000; 82:570–594.
11. Helweg-Larsen S, Sorensen PS. Symptoms and signs in metastatic spinal cord compression: a study of progression from first symptom until diagnosis in 153 patients. Eur J Cancer. 1994; 30A:396–398.
12. Fisher CG, DiPaola CP, Ryken TC, et al. A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group. Spine (Phila Pa 1976). 2010; 35:E1221–E1229.
13. Crim JR, Bassett LW, Gold RH, et al. Spinal neuroarthropathy after traumatic paraplegia. AJNR Am J Neuroradiol. 1988; 9:359–362.
14. Laufer I, Rubin DG, Lis E, et al. The NOMS framework: approach to the treatment of spinal metastatic tumors. Oncologist. 2013; 18:744–751.
15. Lee CS, Jung CH. Metastatic spinal tumor. Asian Spine J. 2012; 6:71–87.
16. Fisher CG, Versteeg AL, Schouten R, et al. Reliability of the spinal instability neoplastic scale among radiologists: an assessment of instability secondary to spinal metastases. AJR Am J Roentgenol. 2014; 203:869–874.
17. Chamberlain MC. Neoplastic meningitis. Neurologist. 2006; 12:179–187.
18. Shapiro WR, Johanson CE, Boogerd W. Treatment modalities for leptomeningeal metastases. Semin Oncol. 2009; 36:S46–S54.
19. Mostardi PM, Diehn FE, Rykken JB, et al. Intramedullary spinal cord metastases: visibility on PET and correlation with MRI features. AJNR Am J Neuroradiol. 2014; 35:196–201.
20. Lee SS, Kim MK, Sym SJ, et al. Intramedullary spinal cord metastases: a single-institution experience. J Neurooncol. 2007; 84:85–89.
21. Eastley N, Newey M, Ashford RU. Skeletal metastases - the role of the orthopaedic and spinal surgeon. Surg Oncol. 2012; 21:216–222.
22. Love RR, Leventhal H, Easterling DV, Nerenz DR. Side effects and emotional distress during cancer chemotherapy. Cancer. 1989; 63:604–612.
23. Cho JH, Ha JK, Hwang CJ, Lee DH, Lee CS. Patterns of treatment for metastatic pathological fractures of the spine: the efficacy of each treatment modality. Clin Orthop Surg. 2015; 7:476–482.